Idursulfase is a medication that is used to treat a rare genetic disorder known as Hunter syndrome, also called mucopolysaccharidosis II (MPS II). This condition is caused by a deficiency of the enzyme iduronate-2-sulfatase, which leads to the accumulation of certain substances in the body’s cells and tissues.

Idursulfase works by replacing the missing enzyme in patients with Hunter syndrome, helping to break down and remove the accumulated substances. This can help to improve symptoms such as joint stiffness, organ enlargement, and respiratory issues that are common in individuals with MPS II.

It is important to note that idursulfase is administered through intravenous infusion, typically in a clinical setting by a healthcare professional. The dosage and frequency of treatment will be determined by your healthcare provider based on your individual needs and response to the medication.

As with any medication, there may be potential side effects associated with idursulfase. These can include allergic reactions, fever, headache, and nausea. It is important to discuss any concerns or potential side effects with your healthcare provider.

Overall, idursulfase has been shown to be an effective treatment for individuals with Hunter syndrome, helping to improve quality of life and manage symptoms associated with this rare genetic disorder. If you or a loved one has been diagnosed with MPS II, speak with your healthcare provider to see if idursulfase may be a suitable treatment option.